Biotechnology Equipment and Materials Archives

NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » news » Biotechnology Equipment and Materials

Danaher to buy protein consumables provider Abcam for $5.7bn

By NS Healthcare Staff Writer

29 Aug 23

Abcam, a UK-based provider of protein-based antibodies, reagents, biomarkers, and assays, will operate as a standalone company and…

PharmaceuticalsBiotechnology Equipment and Materials

Danaher to buy protein consumables provider Abcam for $5.7bn

HebeCell, Logomix partner on next-gen genomically engineered PSC-NK cells

By NS Healthcare Staff Writer

14 Aug 23

As part of the collaboration, Logomix will initially contribute genome editing capabilities to assist HebeCell in creating the…

PharmaceuticalsBiotechnology Equipment and Materials

Astellas to open new life sciences facility in Massachusetts, US

By NS Healthcare Staff Writer

11 Aug 23

The investment will help Astellas to establish a significant presence in life science innovation hotspots in the world…

PharmaceuticalsBiotechnology Equipment and Materials

Applied DNA Sciences buys biotech firm Spindle Biotech

By NS Healthcare Staff Writer

14 Jul 23

The acquisition allows Applied DNA Sciences to leverage its LinearDNA platform, which enables efficient chemical modification of DNA…

PharmaceuticalsBiotechnology Equipment and Materials

Merck invests €23m to expand cell culture media production in Kansas, US

By NS Healthcare Staff Writer

13 Jul 23

Merck will expand its cell culture media production capacity at the Lenexa facility, by installing a new dry…

PharmaceuticalsBiotechnology Equipment and Materials

EQT Private Equity to sell Ellab, following transformation into a leading validation & monitoring provider for the Biotech and Pharmaceutical industries

By NS Healthcare Staff Writer

22 Jun 23

Transformation has resulted in Ellab tripling its revenues, EBITDA and number of employees, while experiencing approximately 20% annual…

PharmaceuticalsBiotechnology Equipment and Materials

Viva Biotech announces strategic investors with $210m investment

By NS Healthcare Staff Writer

16 Jun 23

Since its initial listing, Viva Biotech has successfully completed mergers and acquisitions, including SYNthesis and Langhua Pharmaceutical, resulting…

PharmaceuticalsBiotechnology Equipment and Materials